Monness, Crespi, Hardt Reiterates Sell Rating on Strategy (MSTR), PT $175, 'contraction in the multiple is likely to continue'
Tweet Send to a Friend
Monness, Crespi, Hardt analyst Gus Gala reiterated a Sell rating and $175.00 price target on Strategy (NASDAQ: MSTR).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
